First Predictive Metastasis Marker for Colon Cancer based on Gene 7a5/Prognostin/MACC1
This invention offers the use of the 7a5/prognostin/MACC1 gene to predict whether
colon cancer is likely to spread or metastatsize from its original site by determining the transcriptional levels. In a study with material from 100 patients 1/3 of 100 patients did develop metastasis in the course of 5 years. Clinical validation of marker with over 90% predictability. The Marker was also found in mamma carcinoma.
Weitere Informationen: PDF
ipal GmbH
Tel.: +49 (0)30/2125-4820
Ansprechpartner
Ursula Haufe
